Interleukin-1 signal transduction. Leukocyte-endothelial cell recognition: three or more steps to specificity and diversity. Cell, , 67, Bee venom phospholipase A2-specific T cell clones from human allergic and non-allergic individuals: cytokine patterns change in response to the antigen concentration. Allergy Clin. In vitro binding of synaptic vesicles to the synaptic plasma membrane: lack of effect of beta-bungarotoxin.
Toxicon, , 34, A study of phospholipase A2 induced edema in rat paw. Mechanism and regulation of immunoglobulin isotype switching. The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1. Inflammation and repair.
In: Robbins pathologic basis of disease. Philadelphia: W. Sauders, , Acute inflammation and microthrombosis induced by endotoxin, interleukin-1, tumor necrosis factor and the implications in Gram-negative infection. The role of arachidonic acid products in pain and inflammation.
Interleukin-1, tumor necrosis factor and their specific inhibitors. Interleukin-1 and its biologically related cytokines. The biological properties of interleukin Biological basis for Interleukin-1 in disease. Blood, , 87, Mechanisms of leukocyte motility and chemotaxis. A link between catalytic activity, IgE-independent mast cell activation and allergenicity of bee venom phospholipase A2. Role of interleukin-6 in mediating mesangial cell proliferation and matrix production in vivo. Kidney Int.
Differential effect of glucocorticoids on tumour necrosis factor production in mice: up-regulation by early pretreatment with dexamethasone. Allergy, , 7, IL-4 is required to generate and sustain in vivo IgE response. Chemokine and tissue injury. Processing of tumor necrosis factor alpha precusor by metalloproteinases. Nature, , , Administration of IL during ongoing immune responses fails to permanently suppress and can even enhance the synthesis of antigen- specific IgE.
High endothelial venules HEV : specialized endothelium for lymphocyte migration. Today, , 16, The biology of the eosinophilic leukocyte. Epidemiology of allergy to insect venoms and stings. Allergy Proc. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses. Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the Fc epsilon RI. Role for mast cell-derived transforming growth factor beta and tumor necrosis factor alpha.
Molecular, structural, and biological characteristics of the tumor necrosis factor ligand superfamily. Skeletal muscle regeneration after myonecrosis induced by crude venom and a myotoxin from the snake Bothrops asper Fer-de-Lance. Toxicon, , 22, Skeletal muscle necrosis and regeneration after injection of BaH1, a hemorrhagic metalloproteinase isolated from the venom of the snake Bothrops asper Terciopelo. Bee and wasp venoms. Science, , , Adhesion molecules as regulators of mast-cell and basophil function.
Purification and characterization of a high-affinity binding protein for pancretic-type phospholipase A2. Mast cell proteinases and cytokines in skin inflammation. Bacterial stimulators of macrophges. Biological and clinical aspects of Interleukin Acute phase reaction in rats: independent change of acute phase protein plasma concentration and macroscopic inflammation in primary rat adjuvant inflammation. Agents Actions. Effects of accidental trauma on cytokine and endotoxin production.
Care Med. Insect venom allergy, immunology, and immunotherapy. In: TU, AT. Handbook of neural toxins: insect poisons, allergens, and other intervertebrate venoms. New York: M. Dekker, , 2, Biological properties of interleukin Today, , 13, Modulation of T-cell response to phospholipase A2 and phospholipase A2-derived peptides by conventional bee venom immunotherapy.
Recombinant human interleukinsafety issues of a pleiotropic growth factor. Toxicology, , , Cytokine receptor signaling mechanisms. Antibodies to purified bee venom proteins and peptides. Development of highly specific RAST for bee venom antigens and its application to bee sting allergy. Immunochemical studies of stinging insect venom allergens. A model to explain the pharmacological effects of snake venom phospholipases A2. Toxicon, , 27, Cytokine signal transduction.
Cell, , 76, Stimulation of neutrophils by tumor necrosis factor. Fibrogenic cytokines:the role of immune mediators in the development of scar tissue. Today, , 12, The phenomenon of the acute-phase response. NY Acad. Processing of pro-tumour necrosis factor-a by venom metalloproteinases and their inhibition. Identification and properties of a very high affinity brain membrane-binding site for a neurotoxic phospholipase from Taipan venom.
Properties of receptors for neurotoxic phospholipase A2 in different tissues. Mediators of inflammation. Poly's lament: the neglected role of the polymophonuclear neutrophil in the afferent limb of the immune response. Host response to Bothrops asper snake venom: analysis of edema formation, inflammatory cells, and cytokine release in a mouse model. Potential allergens stimulate the release of mediators of the allergic response from cells of mast cell lineage in the absence of sensitization with antigen-specific IgE.
Bee venom immunotherapy induces a shift in cytokine responses from a Th2 to a Th1 dominant pattern: comparison of rush and conventional immunotherapy. Allergy, , 25, Acute phase proteins, molecular biology, biochemistry and clinical applications. Serum levels of cytokines in patients envenomed by tityus serrulatus scorpion sting. IL-4 enhances programmed cell death apoptosis in stimulated human monocytes.
Negative regulators of the interleukin-1 system: receptor antagonists and decoy receptor. The interleukin-1 receptor complex and interleukin-1 signal transduction. How the glucocorticoids supress immunity. Cytokine, , 1, Biology and biochemistry of chemokines: a family of chemotactic and inflammatory cytokines. CRC Crit Rev. Cytokine receptors and signal transduction. Biology of proinflammatory cytokines and their antagonists.
Allergy to insect stings. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Processing of pro-tumor necrosis factor-alpha by venom metalloproteinases: a hypothesis explaining local tissue damage following snake bite. Type I skin reactivity to native and recombinant phospholipase A2 from honey bee venom is similar. Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody.
Cellular targets and receptors for interleukin Characterization of IL-6 binding and receptors in peripheral blood cells and macrophages. Triggering the degranulation in mast cells by exogenous type II phospholipase A2.
The molecular biology of leukocyte chemoattractant receptors. Relationship of TNF to interleukins. Purification and characterization of an antihemorrhagic factor in the serum of Trimeresurus flavoviridis , a crotalid.
There is more than one interleukin 1. Today, , 7, Properties of the novel proinflammatory supergene intercrine cytokine family. Pathogenesis of hemorrhage induced by bilitoxin, a hemorrhagic toxin isolated from the venom of the common cantil Agkistrodon bilineatus bilineatus.
Toxicon, , 28, Presence of heat-stable hemorrhagic toxins in snake venoms. Melittin and phospholipase A2 from bee Apis mellifera venom cause necrosis of murine skeletal muscle in vivo. Cloning metalloproteinase genes in the carpet viper Echis pyramidum leaklyi. Lymphocyte responses and cytokines. IgE production by normal human lymphocytes is induced by interleukin 4 and supressed by Interferon g and a prostaglandin E2.
USA, , 85, Comparative study of the cytokines profiles induced by B. Cuernavaca: International Society on Toxinology, Control of lymphocyte homing. Physiological and molecular mechanisms of lymphocyte homing. Pharmacology of Hymenoptera venoms. In: AT. TU Ed. Handbook of neural toxins: insect poisons, allegens, and other intervertebrate venoms.
Dekker , , 2, Cytokine regulation of T-cell function: potential for therapeutic intervention. Today, , 14, Kinin formation: mechanisms and role in inflammatory disorders. Cytokine modulation of basophil histamine release in wasp-venom allergy. Allergy, , 49, On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site Inr motif occlusion. Signal transduction in the activation of mast cells and basophils.
Regulation and deregulation of human IgE synthesis. Today, , 11, Lymphokine production by human T cells in disease states. Th1 and Th2 in human diseases.
An update on human Th1 and Th2 cells. Allergy Immunol. Neutrophil receptors and modulation of the immune response. The natural immune system. New York: IRL, , Local tissue damage induced by BaP1, a metalloproteinase isolated from Bothrops asper Terciopelo snake venom. Collectins: pattern-recognition molecules involved in first-line host defense. The interleukin-1 receptor. Allergy to insect stig. Phospholipase A: the major allergen in honey bee venom.
Scorpion envenomation. Intensive Care Med. Interleukin-6 release following scorpion sting in children. Toxicon , , 34, The murine H-2k T cell epitopes of bee venom phospholipase A2 Lie outside the active site of the enzyme.
Implication with respect to paracrine activation of Th2 cells for an IgE antibody response. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Signaling mechanisms through cytokine receptors that share signal transducing receptor components.
Endotoxemic-like shock induced by L. Cuernavaca-Mexico: International Society on Toxinology, Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells.
Recruitment of neutrophils and release of inflammatory mediators induced by Tityus serrulatus venom TsV in the lung of rats. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Differential effects of snake venom phospholipase A2 neurotoxin beta-bungarotoxin and enzyme Naja naja atra on protein kinases. Receptor-dependent mechanism of cell stimulation by bacterial endotoxin.
Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense? Shock, , 3, Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen induced late phase cutaneouse responses. The pathophysiology of tumor necrosis factors.
Soluble and cell surface receptors for tumor necrosis factor. Agents Actions Suppl. Aryl acetic acids. Subsequently, several companies have filed patents on the aryl-acetic-acid template as CRTH2 antagonists, for example, AstraZeneca have patented biaryl-acetic-acid derivatives , , , such as compound 11 Fig.
The biaryl thioether 10 was one of the first-identified CRTH2 chemoattractant receptor-homologous molecule expressed on T H 2 cells antagonists within this structural class with fold functional selectivity for CRTH2 over DP 1. Non-acidic CRTH2 antagonists. The non-acidic CRTH2 antagonists identified so far are dominated by the tetrahydroquinoline structural class. It is most likely that this class of compounds was derived from screening campaigns within pharmaceutical companies as there has been a flurry of patent publications all outlining very similar structures within a short time frame.
The class itself is important because they highlight that potent and selective CRTH2 antagonists can be identified that lack what was assumed to be an essential carboxylic acid within their structure.
Although the lack of a chemical handle from which to derive salts might prove to be a hindrance in terms of solubility and pharmaceutical development of this class of compound they do offer the ability to cross the blood—brain barrier and treat CNS disorders without resorting to a carboxylic-acid prodrug approach.
The first patent applications in the tetrahydroquinoline class were made by Millennium now believed to be licensed to Sanofi—Aventis followed closely by Warner—Lambert now Pfizer.
Millennium disclosed a range of analogues including compound 13 Ref. Warner—Lambert Pfizer have patented similar structures , Fig. Tetrahydroquinoline 13 was one of the first non-acidic CRTH2 chemoattractant receptor-homologous molecule expressed on T H 2 cells antagonists identified. Subsequently compound 14 has been demonstrated to penetrate into the cerebrospinal fluid after oral dosing and possess efficacy in both inflammatory and neuropathic pain models.
K demonstrated an IC 50 of 7. Interestingly, the close analogue K was shown to be a CRTH2 agonist indicating the requirement for an aromatic-group-based amide from the tetrahydroquinoline nitrogen atom to maintain CRTH2-antagonist activity. It is now becoming clear that PGD 2 is an important mediator of allergic responses. The high concentrations produced in response to an allergic stimulation combined with its highly potent activity result in PGD 2 having a dominant role in mediating mast-cell-dependent activation of T H 2 lymphocytes, an effect mediated by CRTH2.
Therefore, PGD 2 produced by mast cells might provide an essential link between the early phase and late-phase allergic responses and such antagonism of PGD 2 provides an attractive target for therapeutic intervention.
There are a number of potent and selective CRTH2 antagonist series identified with drug-like properties and results of ongoing clinical trials in asthma and allergic rhinitis are awaited with interest. The molecular biology and pharmacology of prostaglandin D 2 PGD 2 receptors are discussed elsewhere 94 , The following receptors have an important role in mediating the biological effects of PGD 2. DP 1 or DP.
Such activation by DP 1 -selective agonists such as BWC promotes relaxation of both vascular and airway smooth muscle, which leads to vasodilatation 28 and bronchodilatation 40 , respectively. DP 1 is also expressed by platelets where its activation is linked to an anti-aggregatory function Furthermore, DP 1 is expressed by certain leukocyte populations 47 , 48 , 49 , 50 including dendritic cells, where it controls various functions including cytokine production.
This G q -coupled prostanoid receptor binds thromboxane with high affinity, promoting platelet aggregation and constriction of both vascular and airway smooth muscle.
The bronchoconstrictor effects of TP dominate over the bronchodilator effects of DP 1 in the airways. Originally identified as an orphan receptor that is expressed by T helper 2 T H 2 lymphocytes, chemoattractant receptor-homologous molecule expressed on T H 2 cells CRTH2 is the most recently identified receptor for PGD 2 and mediates its effects by promoting the activation of T H 2 lymphocytes, eosinophils and basophils Urade, Y.
Prostaglandin D2 and sleep regulation. Acta , — Eguchi, N. Lack of tactile pain allodynia in lipocalin-type prostaglandin D synthase-deficient mice.
Natl Acad. USA 96 , — Lewis, R. Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. Peters, S. The role of prostaglandin D2 in IgE-mediated reactions in man. Physicians 95 , — The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells.
Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues. Tanaka, K. Differential production of prostaglandin D2 by human helper T cell subsets. O'Sullivan, S. Allergy Clin. Bochenek, G. Dahlen, S. Monitoring mast cell activation by prostaglandin D2 in vivo. Thorax 59 , — Murray, J. Release of prostaglandin D2 into human airways during acute antigen challenge.
One of the first studies to show that PGD 2 is produced rapidly and in high concentrations in response to an allergen in subjects with allergies. Naclerio, R. Mediator release after nasal airway challenge with allergen. Charlesworth, E. Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen.
Benyon, R. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli. Schulman, E. Anaphylactic release of thromboxane A2, prostaglandin D2, and prostacyclin from human lung parenchyma. Inflammatory mediators in late antigen-induced rhinitis.
Hirai, H. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. Gazi, L. Prostaglandins Other Lipid Mediat. Heinemann, A. Monneret, G. Sandig, H. FEBS Lett. Bohm, E. Forman, B. Cell 83 , — Rossi, A. Nature , — Ide, T. Activation of nuclear receptors by prostaglandins. Flower, R. Inflammatory effects of prostaglandin D2 in rat and human skin. Soter, N. Williams, T.
Role of prostaglandin-mediated vasodilatation in inflammation. Giles, H. The classification of prostaglandin DP-receptors in platelets and vasculature using BW AC, a novel, selective and potent competitive antagonist. Woodward, D. Studies on the ocular pharmacology of prostaglandin D2. The first study to provide evidence that the effects of PGD 2 on eosinophil accumulation in vivo are not DP 1 -mediated. Marsden, K.
The effect of prostaglandin D2 PGD2 on circulating eosinophils. Prostaglandins Leukot. Emery, D. Prostaglandin D2 causes accumulation of eosinophils in the lumen of the dog trachea. Fujitani, Y. Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice. This study demonstrates that the overproduction of PGD 2 enhances allergic airway inflammation.
Raible, D. Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils. Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor.
Blood 98 , — The first definitive study demonstrating that the effects of PGD 2 on eosinophil activation are mediated by a novel receptor. Nagata, K. Selective expression of a novel surface molecule by human Th2 cells in vivo.
CRTH2, an orphan receptor of T-helpercells, is expressed on basophils and eosinophils and responds to mast cell-derived factor s. Coleman, R. Prostanoid-induced contraction of human bronchial smooth muscle is mediated by TP-receptors.
Liston, T. USA 82 , — Beasley, C. Matsuoka, T. Prostaglandin D2 as a mediator of allergic asthma. Science , — This study examines the phenotype of the DP 1 -knockout mouse and demonstrates that DP 1 -receptor activation contributes to T H 2-cytokine production, eosinophil infiltration, mucus production and airway hyperresponsiveness in response to allergic challenge.
Nantel, F. Heavey, D. Effects of intravenous infusions of prostaglandin D2 in man. Prostaglandins 28 , — Doyle, W. Physiologic responses to intranasal dose—response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy.
Johnston, S. The effect of BAY u , a thromboxane receptor antagonist, on prostaglandin D2-induced nasal blockage. Arimura, A. Prevention of allergic inflammation by a novel prostaglandin receptor antagonist, S CAS Google Scholar. Cheng, K. Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans.
USA , — Hammad, H. Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1. Faveeuw, C. Prostaglandin D2 inhibits the production of interleukin in murine dendritic cells through multiple signaling pathways. Gosset, P. Prostaglandin D2 affects the differentiation and functions of human dendritic cells: impact on the T cell response. Effects of prostaglandin D2 on helper T cell functions.
Xue, L. Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells. Gilroy, D. Inducible cyclooxygenase may have anti-inflammatory properties. Nature Med. Ajuebor, M. Cyclooxygenasederived prostaglandin D 2 is an early anti-inflammatory signal in experimental colitis.
Liver Physiol. Trivedi, S. Essential role for hematopoietic prostaglandin D2 synthase in the control of delayed type hypersensitivity. Sugimoto, H. McKenniff, M. BAY u, a potent and selective thromboxane A2 receptor antagonist on airway smooth muscle in vitro. Shichijo, M. Chemoattractant receptor-homologous molecule expressed on Th2 cells activation in vivo increases blood leukocyte counts and its blockade abrogates 13,dihydroketo-prostaglandin D2-induced eosinophilia in rats.
Narita, S. Effects of thromboxane A2 receptor antagonist Bay u on nasal symptoms after antigen challenge in sensitized guinea pigs. Allergy Immunol. Nagai, H. The effect of a thromboxane A2 receptor antagonist BAY-u on experimental allergic reactions.
Prostaglandins 50 , 75—87 Takeshita, K. CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation. Gyles S. Immunology , — Spik, I. Satoh, T. Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor. A study demonstrating that allergic responses are diminished in CRTH2-knockout mice.
Chevalier, E. Chemoattractant receptor-homologous molecule expressed on Th2 cells plays a restricting role on IL-5 production and eosinophil recruitment. Abe, H. Molecular cloning, chromosome mapping and characterization of the mouse CRTH2 gene, a putative member of the leukocyte chemoattractant receptor family. Gene , 71—77 Williams, C.
Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. Wang, Y. Maintenance and polarization of human Th2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells.
Immunity 24 , — Ying, S. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. Angeli, V. Activation of the D prostanoid receptor 1 regulates immune and skin allergic responses. Hardy, C.
The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. Magnussen, H. Effects of a thromboxane-receptor antagonist, BAY u , on prostaglandin D2- and exercise-induced bronchoconstriction. The effects of an oral thromboxane TP receptor antagonist BAY u , on prostaglandin D2- and histamine-induced bronchoconstriction in asthma, and relationship to plasma drug concentrations.
Beasley, R. Con vs. C , Interleukin IL PGs are important soluble mediators involved in the immune response to invading pathogens. COX-2, the major COX isoform in leukocytes, is responsible for the production and regulation of high levels of PG during an inflammatory event [ 5 ].
Although much is known regarding the molecular and cellular regulation of COX-2 and PG, the role of PG in regulating the immune response in malaria and other human infectious diseases is not fully understood. In our studies of Gabonese children with falciparum malaria, we demonstrated a significant reduction of plasma bicyclo-PGE 2 and PBMC cyclooxygenase-2 in children with mild malaria and an even more pronounced decrease in those with severe malaria.
PG produced during inflammation appeared to promote immunosuppression; PGE 2 can inhibit lymphocyte proliferation, cytokine production, migration, and cell-mediated cytotoxicity reviewed in [ 7 ]. In murine models of malaria, enhanced production of PG results in decreased lymphocyte mitogenesis [ 18 ].
Clark and Hunt [ 19 ] postulated that an increase in arachidonate metabolites in peritoneal cells from mice infected with Plasmodium vinckei vinckei elicits the immunosuppression observed in this disease model. Studies in mice show that infection with Leishmania organisms causes increased PG production that suppresses cell-mediated immunity, at least in part, by inhibiting the development of a Th1 response [ 20 ]. Since fever is a hallmark clinical feature of malaria, one might expect increased systemic non-CNS production of PG.
However, systemic production of PGE 2 during inflammation is probably regulated differently than PGE 2 produced within the brain for the generation of the febrile response. PGE 2 in venous blood is completely inactivated during passage through the lungs, and the concentration of PGE 2 delivered to the brain by arterial blood is low [ 23 ]. Peripheral participation in the febrile response may, therefore, involve cytokines not PG, per se produced outside the CNS.
This may in part explain our observation that Gabonese children infected with P. Thus, on the basis of results presented here and on previous observations, we propose that low systemic levels of PGE 2 in children with malaria could augment TNF production and contribute to fever. Although recent studies have noted that P. COX-2 expression is generally increased by proinflammatory cytokines and suppressed by anti-inflammatory cytokines [ 5 ]. The relative balance of pro- and anti-inflammatory cytokines, released as part of an inflammatory event, can regulate high-level output of PG by modulating expression of COX However, the statistically significant inverse correlation between bicyclo-PGE 2 and plasma IL suggests that IL may be responsible for the low levels of COX-2 expression in PBMC from these children who develop high-density parasitemia and severe malarial anemia.
Additional studies that examine the role of PG in cerebral malaria may help to further determine whether reductions in COX-2 and PGE 2 are central to the pathogenesis of malaria. Future studies of COX-2 and PG in malaria should provide valuable information regarding disease pathogenesis and may provide insight into the development of new treatments for this global disease.
Hittner Department of Psychology, College of Charleston, SC for statistical expertise and critical evaluation of the manuscript. Google Scholar. Google Preview. Informed consent was obtained from the parents of participating children.
Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide. Sign In or Create an Account. Sign In. Advanced Search. Search Menu. Article Navigation. Close mobile search navigation Article Navigation. Volume Article Contents Abstract. Subjects and Methods. Perkins , Douglas J. Oxford Academic.
Peter G. Brice Weinberg. Reprints or correspondence: Dr.
0コメント